Published in Ann Intern Med on March 15, 2005
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment (DTE) | NCT01739972
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
Hormone replacement after thyroid and parathyroid surgery. Dtsch Arztebl Int (2010) 1.88
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J (2012) 1.32
Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab (2011) 1.04
Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther (2011) 1.02
Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging (2012) 1.00
The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol (Oxf) (2010) 0.96
Hypothyroidism and depression. Eur Thyroid J (2013) 0.90
Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol (2007) 0.85
Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nat Rev Endocrinol (2015) 0.82
Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract (2005) 0.81
Effects of Levothyroxine Replacement or Suppressive Therapy on Energy Expenditure and Body Composition. Thyroid (2016) 0.78
The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition. J Clin Endocrinol Metab (2014) 0.78
Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects. Thyroid (2016) 0.76
L-thyroxine plus liothyronine in hypothyroidism. Ann Intern Med (2005) 0.75
Severe TSH Elevation and Pituitary Enlargement After Changing Thyroid Replacement to Compounded T4/T3 Therapy. J Investig Med High Impact Case Rep (2016) 0.75
Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study. Eur Thyroid J (2017) 0.75
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Treatment and blood pressure control in Spain during 2002-2010. J Hypertens (2012) 2.13
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol (2010) 1.94
[PREVENCAT study: control of cardiovascular risk in primary care]. Med Clin (Barc) (2005) 1.76
Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res (2004) 1.65
[Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism]. Rev Esp Cardiol (2008) 1.51
Copper and zinc serum levels after derivative bariatric surgery: differences between Roux-en-Y Gastric bypass and biliopancreatic diversion. Obes Surg (2011) 1.51
Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens (2002) 1.49
Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J Hypertens (2012) 1.45
Evolution of therapy inertia in primary care setting in Spain during 2002-2010. J Hypertens (2014) 1.41
When office blood pressure measurement is not enough. Int J Cardiol (2009) 1.39
Importance of electrocardiographic left ventricular hypertrophy in blood pressure control. J Hypertens (2011) 1.39
Blood pressure control in hypertensive women aged 65 years or older in a primary care setting. MERICAP study. Rev Esp Cardiol (2011) 1.38
The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab (2005) 1.37
Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax (2010) 1.30
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med (2006) 1.27
Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.16
Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab (2004) 1.10
Hypertension and children: should we be aware? Hypertension (2013) 1.10
New blood pressure control goals, more rational but facilitating therapeutic inertia? J Hypertens (2013) 1.09
[Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia]. Rev Esp Cardiol (2004) 1.06
The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab (2002) 1.02
Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab (2004) 1.02
Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res (2003) 1.01
A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.97
Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid (2006) 0.96
Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain. Clin Endocrinol (Oxf) (2009) 0.96
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.92
Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod (2007) 0.92
Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care (2005) 0.90
REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab (2005) 0.90
Genetic basis of end-stage hypertrophic cardiomyopathy. Eur J Heart Fail (2011) 0.89
Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril (2003) 0.89
Obesity, blood pressure, and cardiovascular outcomes. Lancet (2013) 0.89
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care (2007) 0.88
Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.88
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr Relat Cancer (2004) 0.87
Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes. BMC Med Genomics (2010) 0.86
Evolution of blood pressure control in Spain. J Hypertens (2007) 0.86
Relative safety profiles of high dose statin regimens. Vasc Health Risk Manag (2008) 0.86
Blood pressure control and physicians' therapeutic behavior in a very elderly Spanish hypertensive population. Hypertens Res (2009) 0.86
Sudden death after arteriovenous fistula ligation in a renal transplant patient. Ann Vasc Surg (2007) 0.85
Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density. Obes Surg (2010) 0.85
Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril (2002) 0.84
Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome. Diabetes Care (2006) 0.83
Treatment of allograft vasculopathy in heart transplantation. Expert Opin Pharmacother (2006) 0.82
Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril (2002) 0.81
Mesoscopic effects in an agent-based bargaining model in regular lattices. PLoS One (2011) 0.81
Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study. Clin Exp Hypertens (2010) 0.80
Validation of the Spanish version of the Kansas city cardiomyopathy questionnaire. Rev Esp Cardiol (2010) 0.80
Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials. Adv Ther (2012) 0.80
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. Eur J Heart Fail (2010) 0.80
An evaluation of the latest evidence relating to renin-angiotensin system inhibitors. Expert Opin Drug Metab Toxicol (2013) 0.79
The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance. Eur J Endocrinol (2006) 0.79
Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study. J Am Soc Nephrol (2006) 0.79
The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal. Eur J Endocrinol (2005) 0.79
High heart rate: more than a risk factor. Lessons from a clinical practice survey. Int J Cardiol (2008) 0.79
Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients. Eur Heart J (2011) 0.78
Rosuvastatin and cardiovascular continuum when time is important. J Am Coll Cardiol (2010) 0.78
[Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital]. Cir Esp (2007) 0.78
[Diagnostic localization of insulinoma and prognostic value of postoperative glycemia monitoring]. Med Clin (Barc) (2002) 0.77
Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. Rev Esp Cardiol (Engl Ed) (2012) 0.77
Concomitance of cardiovascular comorbidities in the hypertensive population: not only in the United States. Arch Intern Med (2008) 0.77
Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study. J Clin Hypertens (Greenwich) (2010) 0.77
Combined therapy in the treatment of hypertension. Fundam Clin Pharmacol (2009) 0.77
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant (2013) 0.77
High resting heart rate: a cardiovascular risk factor or a marker of risk? Eur Heart J (2008) 0.77
Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Rev Cardiovasc Ther (2013) 0.77
Effects of bariatric surgery on male obesity-associated secondary hypogonadism: comparison of laparoscopic gastric bypass with restrictive procedures. Obes Surg (2014) 0.77
The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women. Hum Reprod (2006) 0.77
Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens (2006) 0.76
Screening in a Lactobacillus delbrueckii subsp. bulgaricus collection to select a strain able to survive to the human intestinal tract. Nutr Hosp (2013) 0.76
Ultrashort bowel syndrome: surgical management and long-term results of an exceptional case. J Pediatr Surg (2008) 0.76
Utilization of non-AUG initiation codons in a flow cytometric method for efficient selection of recombinant cell lines. Biotechnol Bioeng (2011) 0.76
Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study. J Clin Hypertens (Greenwich) (2008) 0.76
Renal insufficiency should be included in stroke risk scores. Kidney Int (2013) 0.76
Emerging drug combinations to optimize renovascular protection and blood pressure goals. Int J Nephrol Renovasc Dis (2012) 0.76
Diagnostic accuracy of computer-assisted electrocardiography in the diagnosis of left ventricular hypertrophy in left bundle branch block. Rev Esp Cardiol (Engl Ed) (2011) 0.76
Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension. Expert Opin Pharmacother (2012) 0.76
Importance of identifying renal disease early. Rev Esp Cardiol (2010) 0.75
Cardiovascular protection with candesartan in patients with metabolic disorders. Hypertens Res (2010) 0.75
Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women". Circulation (2010) 0.75
[Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology]. Rev Esp Cardiol (2011) 0.75
High heart rate: more data for a question unresolved. Am J Cardiol (2009) 0.75
Renal function and coronary disease: not only in clinical trials. Int J Cardiol (2009) 0.75
Anticoagulation in non-valvular atrial fibrillation: underused or wrongly used? Am J Cardiol (2011) 0.75
Resistant hypertension. What is the best approach? Rev Esp Cardiol (2009) 0.75
Treating heart rate for the prevention of diabetes: the next step? Am J Hypertens (2009) 0.75
Angiotensin-receptor blockade, cancer, and concerns. Lancet Oncol (2010) 0.75
Ischemic heart disease and women: more answers are needed. Rev Esp Cardiol (Engl Ed) (2012) 0.75